Transcend Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$441K Sell
2,087
-232
-10% -$50K 0.04% 411
2025
Q4
$477K Sell
2,319
-146
-6% -$27.5K 0.04% 371
2025
Q3
$387K Sell
2,465
-172
-7% -$26.6K 0.03% 448
2025
Q2
$443K Sell
2,637
-109
-4% -$16.2K 0.03% 355
2025
Q1
$378K Buy
2,746
+11
+0.4% +$1.4K 0.03% 422
2024
Q4
$323K Buy
2,735
+96
+4% +$11.2K 0.02% 425
2024
Q3
$292K Buy
2,639
+436
+20% +$45.6K 0.02% 484
2024
Q2
$217K Buy
+2,203
New +$224K 0.02% 537

Other funds holding CAH

Transcend Capital Advisors's CAH Position: Q1 2026 in Review

Transcend Capital Advisors reduced its Cardinal Health (CAH) stake by 10% in Q1 2026, selling an estimated $50K and leaving 2,087 shares worth $441K. The position accounts for 0.04% of the portfolio, ranked #411.

Transcend Capital Advisors first reported a position in CAH in Q2 2024 and has held it in 8 quarters since. The position peaked at $477K in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Transcend Capital Advisors held 2,087 shares of Cardinal Health worth $441K as of Q1 2026.
  • Transcend Capital Advisors sold 232 Cardinal Health shares in Q1 2026, an estimated $50K.
  • Cardinal Health made up 0.04% of Transcend Capital Advisors's portfolio in Q1 2026, its #411 holding.
  • Transcend Capital Advisors first reported a position in Cardinal Health in Q2 2024 and has held it in 8 quarters since.
  • Transcend Capital Advisors's Cardinal Health position peaked at $477K in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.